John Harrison

Conference Host

John Harrison

Conference Host

Biography

Conference host and Prof. Principal Consultant Metis Cognition Ltd., United Kingdom

Dr. John Harrison is Associate Professor at the Alzheimer Center of the VUmc in Amsterdam. Metis is an applied psychology practice, established to advise pharmaceutical companies on the selection and successful integration of cognitive testing into their development programs.

Metis provides consultancy to more than 30 companies involved in the development of new drugs for various indications, including Alzheimer’s disease, depression and schizophrenia. John has more than 20 years’ commercial experience and extensive knowledge of neuropsychological assessment, gained primarily during post-doctoral research fellowships at Cambridge University and Imperial College London. He routinely speaks on the use of cognitive testing at international meetings, including the American Alzheimer’s Association roundtable and the European Task Force for Alzheimer’s disease. He is a member of the American Psychological Association, holds Chartered Psychologist status with the British Psychological Society, and Chartered Scientist status with the UK Science Council. He has authored/co-authored many books and scientific articles, including a popular neuroscience book ‘Synaesthesia: The Strangest Thing’.

He will complete a degree in classical studies this year and is currently studying a second PhD entitled ‘Myth in reception: Insights from Stourhead house and gardens 1714-1830’. John has maintained a keen interest in computer gaming since participating in the creation of ‘EVE’ with Peter Gabriel in 1996.

John Harrison

Conference Host

Biography

Conference host and Prof. Principal Consultant Metis Cognition Ltd., United Kingdom

Dr. John Harrison is Associate Professor at the Alzheimer Center of the VUmc in Amsterdam. Metis is an applied psychology practice, established to advise pharmaceutical companies on the selection and successful integration of cognitive testing into their development programs.

Metis provides consultancy to more than 30 companies involved in the development of new drugs for various indications, including Alzheimer’s disease, depression and schizophrenia. John has more than 20 years’ commercial experience and extensive knowledge of neuropsychological assessment, gained primarily during post-doctoral research fellowships at Cambridge University and Imperial College London. He routinely speaks on the use of cognitive testing at international meetings, including the American Alzheimer’s Association roundtable and the European Task Force for Alzheimer’s disease. He is a member of the American Psychological Association, holds Chartered Psychologist status with the British Psychological Society, and Chartered Scientist status with the UK Science Council. He has authored/co-authored many books and scientific articles, including a popular neuroscience book ‘Synaesthesia: The Strangest Thing’.

He will complete a degree in classical studies this year and is currently studying a second PhD entitled ‘Myth in reception: Insights from Stourhead house and gardens 1714-1830’. John has maintained a keen interest in computer gaming since participating in the creation of ‘EVE’ with Peter Gabriel in 1996.